SOPHiA GENETICS SA
BioSniper Score
2-factor signal · derived from public data
N/A
D/E 2.46 · 0% dilution
N/A
N/A
N/A
1 buy · 77 sells (180d)
A transparent, data-derived signal for SOPHiA GENETICS SAacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$359.7M
Cash
$37.5M
Quarterly Burn
—
Runway
—
Revenue
—
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
46
Total value held
$100.9M
| Holder | Shares | Value |
|---|---|---|
| generation investment management llp | 6,789,560 | $33.6M |
| akre capital management llc | 3,719,140 | $18.4M |
| banque pictet & cie sa | 2,208,280 | $10.9M |
| royce & associates lp | 1,816,312 | $9.0M |
| principal financial group inc | 1,409,242 | $7.0M |
| kennedy capital management llc | 927,800 | $4.6M |
| essex investment management co llc | 692,809 | $3.4M |
| archon capital management llc | 441,413 | $2.2M |
| hodges capital management inc. | 435,836 | $2.2M |
| sei investments co | 357,888 | $1.8M |
Showing top 10 of 46 institutional holders of SOPHiA GENETICS SA. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
What is SOPHiA GENETICS SA's market capitalization?
SOPHiA GENETICS SA's market capitalization is approximately $359.7M.
Who is the CEO of SOPHiA GENETICS SA?
Dr. Jurgi Camblong M.B.A., Ph.D. is the chief executive officer of SOPHiA GENETICS SA (SOPH).
Get the full picture on SOPHiA GENETICS SA
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.